- Home
- HWKN vs JANX Comparison
HWKN vs JANX Comparison
Compare HWKN & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWKN
- JANX
- Stock Information
- Founded
- HWKN 1938
- JANX 2017
- Country
- HWKN United States
- JANX United States
- Employees
- HWKN N/A
- JANX N/A
- Industry
- HWKN Specialty Chemicals
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- HWKN Consumer Discretionary
- JANX Health Care
- Exchange
- HWKN Nasdaq
- JANX Nasdaq
- Market Cap
- HWKN 2.2B
- JANX 2.2B
- IPO Year
- HWKN N/A
- JANX 2021
- Fundamental
- Price
- HWKN $110.66
- JANX $28.25
- Analyst Decision
- HWKN Hold
- JANX Strong Buy
- Analyst Count
- HWKN 1
- JANX 8
- Target Price
- HWKN $122.00
- JANX $91.25
- AVG Volume (30 Days)
- HWKN 98.9K
- JANX 753.1K
- Earning Date
- HWKN 05-14-2025
- JANX 05-06-2025
- Dividend Yield
- HWKN 0.66%
- JANX N/A
- EPS Growth
- HWKN 12.32
- JANX N/A
- EPS
- HWKN 3.91
- JANX N/A
- Revenue
- HWKN $952,133,000.00
- JANX $10,588,000.00
- Revenue This Year
- HWKN $6.21
- JANX N/A
- Revenue Next Year
- HWKN $5.81
- JANX $289.47
- P/E Ratio
- HWKN $27.93
- JANX N/A
- Revenue Growth
- HWKN 3.01
- JANX 30.99
- 52 Week Low
- HWKN $71.98
- JANX $26.07
- 52 Week High
- HWKN $139.55
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- HWKN 58.37
- JANX 37.43
- Support Level
- HWKN $103.55
- JANX $29.77
- Resistance Level
- HWKN $107.28
- JANX $32.00
- Average True Range (ATR)
- HWKN 2.84
- JANX 1.52
- MACD
- HWKN 0.65
- JANX 0.03
- Stochastic Oscillator
- HWKN 100.00
- JANX 34.55
About HWKN Hawkins Inc.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.